| Date Filed | Type | Description |
| 10/03/2023 |
4
| RAPP MICHAEL (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 253,806 shares
@ $5.91, valued at
$1.5M
|
|
| 06/12/2023 |
4
| RAPP MICHAEL (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 6,500 options to buy
@ $4.84, valued at
$31.5k
|
|
| 01/17/2023 |
4
| RAPP MICHAEL (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 17,500 shares
@ $4, valued at
$70k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
SC 13G
| RAPP MICHAEL reports a 10% stake in Immunome, Inc. |
| 02/05/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/07/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/05/2020 |
4
| RAPP MICHAEL (10% Owner) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 7,500 options to buy
@ $11.38, valued at
$85.4k
|
|
| 10/08/2020 |
4
| RAPP MICHAEL (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Converted 555,554 shares
@ $0
Bought 83,332 shares
@ $12, valued at
$1000k
Converted 555,554 convertible preferred
@ $0
Converted 166,666 warrants
@ $9, valued at
$1.5M
|
|
| 10/01/2020 |
3
| RAPP MICHAEL (Director) has filed a Form 3 on Immunome Inc. |
| 01/15/2019 |
SC 13G/A
| RAPP MICHAEL reports a 8.4% stake in ZYNERBA PHARMACEUTICALS, INC. |
| 05/31/2018 |
4
| RAPP MICHAEL (10% Owner) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Bought 5,885 shares
@ $10.45, valued at
$61.5k
|
|
| 05/02/2018 |
4
| RAPP MICHAEL (10% Owner) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Bought 15,000 shares
@ $10.463, valued at
$156.9k
|
|
| 03/23/2018 |
4
| RAPP MICHAEL (10% Owner) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Bought 10,000 shares
@ $9.279, valued at
$92.8k
|
|
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/23/2017 |
4
| RAPP MICHAEL (10% Owner) has filed a Form 4 on Zynerba Pharmaceuticals, Inc. |
| 02/16/2017 |
SC 13G/A
| Zynerba Pharmaceuticals, Inc. reports a 13.6% stake in ZYNERBA PHARMACEUTICALS, INC. |
| 12/29/2016 |
4
| RAPP MICHAEL (10% Owner) has filed a Form 4 on Zynerba Pharmaceuticals, Inc. |
| 03/28/2016 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 02/16/2016 |
4
| RAPP MICHAEL (10% Owner) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Acquired 80,467 shares
@ $0 |
|
| 08/10/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/28/2013 |
SC 13D/A
| RAPP MICHAEL reports a 6.9% stake in Committed Capital Acquisition Corporation |
| 10/18/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/25/2013 |
4
| RAPP MICHAEL (President and Chairman) has filed a Form 4 on COMMITTED CAPITAL ACQUISITION Corp|
Txns:
| Disposed of 75,750 shares
@ $0
Disposed of 121,500 shares
@ $0 |
|
| 06/20/2012 |
4
| RAPP MICHAEL (President and Chairman) has filed a Form 4 on COMMITTED CAPITAL ACQUISITION Corp|
Txns:
| Disposed of 176,000 shares
@ $0
Acquired 93,250 shares
@ $0 |
|
| 03/05/2012 |
4
| RAPP MICHAEL (President and Chairman) has filed a Form 4 on COMMITTED CAPITAL ACQUISITION Corp|
Txns:
| Sold 100,000 shares
@ $0
Bought 10,214 shares
@ $0 |
|
| 11/01/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 10/03/2011 |
SC 13G
| PLASTRON ACQUISITION CORP III reports a 26.7% stake in Plastron Acquisition Corp. III |
|